NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Woolsey Pharmaceuticals

Woolsey Pharmaceuticals

Private
New York City, New YorkHealthcare & Life Scienceshttps://woolseypharma.com/

Last Round

Series B

Extension

Feb 27, 2025

Total Funding Raised

$19.7M

Company Overview

Woolsey Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on developing and repurposing therapeutics for the treatment of neurodegenerative diseases such as ALS.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

drug repurposingamyotrophic lateral sclerosisALSneurodegenerative diseaseRho-kinase inhibitorROCK inhibitorclinical-stage biotechfasudilneuroinflammationclinical trialsorphan drugbiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Woolsey Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Woolsey Pharmaceuticals comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Woolsey Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionFeb 27, 2025
Series BOct 1, 2021
VC RoundMar 11, 2020

Woolsey Pharmaceuticals Investors

Notable investors and investment history

Woolsey Pharmaceuticals investors
InvestorRounds
Rapaski Capital GroupSeries B Extension, Series B
Nelstone VenturesSeries B Extension, Series B

Woolsey Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Woolsey Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Woolsey Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range1
Year Founded2019
Last FundingFeb 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.